Archive - May 2018
Astellas Sells Research Facilities to Gilead s Kite Pharma
Biogen, Ionis Expand $1-Billion Neurological Disease Alliance
Fresenius Terminates $4.3-Billion Merger with Akron
Gilead partners with Alphabet’s Verily for immune cell profiling
Voice Technology and AI: Powering Patient Experience & Expectations
Sanofi, Regeneron cut heart drug prices for greater patient access
Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more
Gilead and Verily team up to map inflammatory diseases